Floatz logo

Belinostat

Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11

National Cancer Institute (NCI)Small moleculePhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 cohort.

Asset / SponsorPhaseRating
Daunorubicin
National Cancer Institute (NCI)
Phase 3BBB
Cytosin-Arabinosid
Alice Mims
Phase 3BBB
Fludarabine
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2BBB
Idarubicine
Bruno C. Medeiros
Phase 2BBB
ETOPOSIDE
Alice Mims
Phase 3BBB

View all 50 →

Same molecule, other indications

Belinostat is also rated in:

HIV InfectionsDormant
BB
Indicative ·
67 / 100
View asset →
ovarian carcinomaDormant
BB
Indicative ·
65 / 100
View asset →
diffuse large B-cell lymphomaDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →